KRONOS WORLDWIDE INC (KRO)

US50105F1057 - Common Stock

11.29  0 (0%)

Fundamental Rating

3

KRO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. The financial health of KRO is average, but there are quite some concerns on its profitability. KRO is valied quite expensively at the moment, while it does show a decent growth rate. Finally KRO also has an excellent dividend rating.



2

1. Profitability

1.1 Basic Checks

KRO had negative earnings in the past year.
In the past year KRO had a positive cash flow from operations.
KRO had positive earnings in 4 of the past 5 years.
Each year in the past 5 years KRO had a positive operating cash flow.

1.2 Ratios

The Return On Assets of KRO (-2.67%) is worse than 72.62% of its industry peers.
The Return On Equity of KRO (-6.07%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -2.67%
ROE -6.07%
ROIC N/A
ROA(3y)2.78%
ROA(5y)3.18%
ROE(3y)5.94%
ROE(5y)7.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 9.89%, KRO is doing worse than 85.71% of the companies in the same industry.
In the last couple of years the Gross Margin of KRO has declined.
KRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.71%
GM growth 5Y-21.8%

4

2. Health

2.1 Basic Checks

KRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KRO has been reduced compared to 1 year ago.
Compared to 5 years ago, KRO has less shares outstanding
The debt/assets ratio for KRO is higher compared to a year ago.

2.2 Solvency

KRO has an Altman-Z score of 1.86. This is not the best score and indicates that KRO is in the grey zone with still only limited risk for bankruptcy at the moment.
KRO's Altman-Z score of 1.86 is in line compared to the rest of the industry. KRO outperforms 45.24% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that KRO is somewhat dependend on debt financing.
KRO's Debt to Equity ratio of 0.55 is in line compared to the rest of the industry. KRO outperforms 53.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACCN/A
WACC7.63%

2.3 Liquidity

A Current Ratio of 3.01 indicates that KRO has no problem at all paying its short term obligations.
KRO's Current ratio of 3.01 is fine compared to the rest of the industry. KRO outperforms 77.38% of its industry peers.
KRO has a Quick Ratio of 1.49. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
KRO has a Quick ratio (1.49) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.01
Quick Ratio 1.49

4

3. Growth

3.1 Past

The earnings per share for KRO have decreased strongly by -147.78% in the last year.
The Revenue for KRO has decreased by -13.66% in the past year. This is quite bad
KRO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.06% yearly.
EPS 1Y (TTM)-147.78%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q72.22%
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y0.56%
Revenue growth 5Y0.06%
Revenue growth Q2Q16.85%

3.2 Future

The Earnings Per Share is expected to grow by 59.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.08% on average over the next years. This is quite good.
EPS Next Y192.78%
EPS Next 2Y93.34%
EPS Next 3Y59.83%
EPS Next 5YN/A
Revenue Next Year19.24%
Revenue Next 2Y13.5%
Revenue Next 3Y11.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRO. In the last year negative earnings were reported.
KRO is valuated quite expensively with a Price/Forward Earnings ratio of 28.30.
61.90% of the companies in the same industry are cheaper than KRO, based on the Price/Forward Earnings ratio.
KRO is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 28.3

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KRO's earnings are expected to grow with 59.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.34%
EPS Next 3Y59.83%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.44%, KRO is a good candidate for dividend investing.
KRO's Dividend Yield is rather good when compared to the industry average which is at 3.21. KRO pays more dividend than 92.86% of the companies in the same industry.
KRO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 6.44%

5.2 History

The dividend of KRO has a limited annual growth rate of 2.22%.
KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
KRO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.22%
Div Incr Years0
Div Non Decr Years11

5.3 Sustainability

The earnings of KRO are negative and hence is the payout ratio. KRO will probably not be able to sustain this dividend level.
KRO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-178.21%
EPS Next 2Y93.34%
EPS Next 3Y59.83%

KRONOS WORLDWIDE INC

NYSE:KRO (4/19/2024, 12:58:21 PM)

11.29

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.30B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 6.44%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.3
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.67%
ROE -6.07%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 9.89%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.01
Quick Ratio 1.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-147.78%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y192.78%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y0.56%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y